Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Christopher Dowrick a the Outcomes
of Depression International Network (ODIN)
GroupDepartment of Primary Care, University of
Liverpool, Liverpool L69 3GB, b School of Epidemiological and Health Sciences, University of
Manchester, Manchester M13 9PT, c Unit for Research
into Social Psychiatry, University Hospital `Marques de Valdecilla,'
39008 Santander, Spain, d Institute of General Practice
and Community Medicine, University of Oslo, PO Box 1130, Blindern,
N-0317 Oslo, Norway, e STAKES Mental
Health Research and Development Group, Mestarinkatu 2D, FIN-20810
Turku, Finland, f Mater Misericordiae Hospital, University College Dublin,
Dublin 7, Ireland, g Division of General Practice, University of Wales
College of Medicine, Wrexham LL13 7YP, h Department of Psychiatry, University of
Liverpool, Liverpool L69 3BX
Correspondence to: C Dowrick cfd{at}liv.ac.uk
| |
Abstract |
|---|
|
|
|---|
Objectives:
To determine the acceptability of two
psychological interventions for depressed adults in the community and
their effect on caseness, symptoms, and subjective function.
Depressive disorders are common major sources of personal
distress and social disability.1 Most treatment is carried
out in primary care, yet many depressed people do not receive
health interventions.
2 3
Pharmacotherapy is effective in
clinical trials, but public opinion favours psychological
treatments.4-7
The outcomes of depression international network (ODIN) is a
European project studying the prevalence and outcomes of depression in
urban and rural communities.8 One objective was to assess the efficacy of psychological interventions. We identified two simple,
reproducible interventions that could be delivered in the community
without complex healthcare infrastructures or expensive health professionals.
Problem solving treatment has three main steps: patients' symptoms are
linked with their problems, problems are defined and clarified, and an
attempt is made to solve the problems in a structured way. The
treatment involves six individual sessions Group psychoeducation emphasises instruction not therapy and promotes
relaxation, positive thinking, pleasant activities, and social skills.
The coping with depression course comprises 12 two hour sessions over
eight weeks, with class reunions,12 whereas the course on
prevention of depression comprises eight sessions.13
Psychoeducation has been used in healthcare and community settings and
seems effective in prevention and quality improvement programmes in US
primary care.14-16
This arm of the outcomes of depression international network
aimed to measure (a) the acceptability of problem solving
treatment and the course on prevention of depression to people with
depressive disorders identified through a community survey,
(b) their impact on depressive caseness, symptoms, and
subjective function, and (c) their cost effectiveness. We
present findings on acceptability of the two treatments, caseness,
symptoms, and subjective function.
Study sites and populations
Study design
Table 1.
Design:
A pragmatic multicentre randomised controlled trial, stratified by centre.
Setting:
Nine urban and rural communities in Finland, Republic of Ireland, Norway, Spain, and the United Kingdom.
Participants:
452 participants aged 18 to 65, identified through a community survey with depressive or adjustment
disorders according to the international classification of diseases,
10th revision or Diagnostic and Statistical Manual of Mental
Disorders, fourth edition.
Interventions:
Six individual sessions of problem
solving treatment (n=128), eight group sessions of the course on
prevention of depression (n=108), and controls (n=189).
Main outcome measures:
Completion rates for each
intervention, diagnosis of depression, and depressive symptoms and
subjective function.
Results:
63% of participants assigned to problem
solving and 44% assigned to prevention of depression completed their
intervention. The proportion of problem solving participants depressed
at six months was 17% less than that for controls, giving a number
needed to treat of 6; the mean difference in Beck depression inventory score was -2.63 (95% confidence interval -4.95 to
-0.32), and there were significant improvements in SF-36 scores.
For depression prevention, the difference in proportions of depressed
participants was 14% (number needed to treat of 7); the mean
difference in Beck depression inventory score was -1.50
(-4.16 to 1.17), and there were significant improvements in SF-36
scores. Such differences were not observed at 12 months. Neither
specific diagnosis nor treatment with antidepressants affected outcome.
Conclusions:
When offered to adults with depressive
disorders in the community, problem solving treatment was more
acceptable than the course on prevention of depression. Both
interventions reduced caseness and improved subjective function.
![]()
Introduction
Top
Abstract
Introduction
Participants and methods
Results
Discussion
References
less than four
hours' therapist time9
and is easily taught
to a range of health professionals. It is as effective as
pharmacotherapy for major depression in primary care
10 11
but has not yet been tested in community settings.
![]()
Participants and methods
Top
Abstract
Introduction
Participants and methods
Results
Discussion
References
The outcomes of depression international network involved
nine study sites in Finland, Republic of Ireland, Norway, Spain, and
the United Kingdom. Cases of depressive disorders were identified by a
two stage community survey between autumn 1996 and spring
1998.17 The Beck depression inventory was used to screen
potential cases. This was followed by a standardised diagnostic interview, including the schedule for clinical assessment in
neuropsychiatry version 2.0 to assign caseness according to the
Diagnostic and Statistical Manual of Mental Disorder, fourth
edition or the international classification of diseases, 10th revision,
and SF-36 for subjective assessment of function.18-20
Cases were offered follow up interviews six and 12 months later.
Ethical approval was obtained according to local protocols. Details of
our survey methods, including translation, training, and quality
control procedures, have been published.8
We undertook a pragmatic randomised controlled trial,
comparing outcomes of problem solving treatment or the depression
prevention course with controls receiving no intervention. Problem
solving was offered at a location most suitable to the participant,
usually their own home. For group psychoeducation we used a
modified course for prevention of depression, with sessions lasting 2.5 hours and with more social support than in the original course on
prevention of depression. Each intervention was offered at five
sites (table 1) and was delivered by facilitators with qualifications
in psychology, nursing, or allied health
professions.
Cases were randomly allocated to one
of the trial groups. Inclusion criteria were (a) age 18 to
65, (b) depressive episodes according to the international
classification of diseases, 10th revision, dysthymia, or adjustment
disorder, or (c) depressive disorders according to the
Diagnostic and Statistical Manual of Mental Disorders,
fourth edition, dysthymia, adjustment disorder, bereavement, or other
depressive disorders. Exclusion criteria were comorbid psychotic
condition, current drug or alcohol related disorder, or major suicide
risk. Concurrent treatment with antidepressants was not an
exclusion criterion. At each study site the unit of randomisation was
the participant. Allocation schedules were generated by random number
tables and administered by staff not in contact with the participants.
Given the nature of the intervention, it was not possible to conceal
group allocation from either investigators or participants at follow up.
Statistical methods
The number of participants recruited fell far short
of those planned in the original sample size calculations, which were
optimistically intended to test the effectiveness of the interventions
at each centre separately.8 Here, however, we are
concerned with estimation and testing the therapy effects for the
centres combined. Revised sample size requirements were calculated on
the basis of the outcomes of the Beck depression inventory and schedule
for clinical assessment in neuropsychiatry, using a two sided 5%
significance level, and assuming a ratio of 1:1:2 for problem solving,
depression prevention, and controls. Given the uncertainty of outcome
from a study based outside healthcare settings, we made no assumptions
concerning the difference in efficacy of problem solving and prevention
of depression. Our data have limited power to differentiate the effects
of the two forms of therapy. Our trial contained around 200 patients
receiving treatment and around 200 controls. These sample sizes are
sufficient to have about 85% power to detect a difference between
treatment and control groups of 2.5 (8 SD) points on the Beck
depression inventory with Student's t test. For the
schedule for clinical assessment in neuropsychiatry, with the outcome
being "no longer a case," the trial has about 85% power to detect
a 15% difference (35% recovery in controls versus 50% for therapy,
odds ratio=0.54) in outcome between interventions and control with a
Pearson
2 test. The corresponding power for
comparing individual therapies with the controls (i.e. using 100 patients per group) is about 60%.
| |
Results |
|---|
|
|
|---|
Characteristics of the sample
Overall, 452 people were identified as cases through the
survey phase of the project of the outcomes of depression international
network. Those who responded to the survey were more likely to be
female and older than non-responders: the sex difference was
significant at three sites.23 Randomisation and assessment
were correctly undertaken for 425 people
26 people recruited in Dublin were excluded post hoc from the analysis, after discovery of a breach in protocol by a former member of the Irish
research team, and one participant with a psychotic condition was
excluded from the Norwegian sample (figure). Table 2
shows the baseline socioeconomic profiles of
participants in each of the three arms. Diagnoses for 412 participants
were based on the international classification of diseases, 10th
revision: 238 (58%) single depressive episodes and 82 (20%) recurrent
depressive episodes, 58 (14%) dysthymia, 21 (5%) adjustment disorder,
and 13 (3%) others. Diagnoses for 418 participants were based on the DSM-IV: 216 (52%) single major depressive disorders and 81 (19%) recurrent major depressive disorders, 67 (16%) dysthymia, 18 (4%) adjustment disorders, and 36 (9%) others. Of 394 participants with
available data, 102 (26%) reported currently taking antidepressants. There were no significant differences in diagnosis or antidepressant receipt between the study sites or the intervention
arms.
|
|
three in
Ireland, seven in Norway, and one in the United
Kingdom.
|
2=17.52, df=8, P=0.025) and
12 months (
2=21.47, df=8, P=0.006). No significant
differences were found in follow up rates between the three trial
groups at either six or 12 months. From a logistic regression analysis
for the whole sample the probability of providing a follow up interview
decreased with increasing baseline score on the Beck depression
inventory: at six months
=
0.017 (0.013 SE); P=0.203 and at 12 months
=
0.025 (0.013 SE), P=0.047.
Acceptability of the interventions
Acceptability was assessed by comparing the proportions of
participants who refused or failed to attend an initial session, who
discontinued an intervention, and who completed their assigned
intervention (table 4). Participants who were randomised to problem
solving were significantly more likely than those who were randomised
to prevention of depression to complete the intervention
(
2=7.61, df=1, P=0.006).
|
2=52.71 df=3, P<0.001) and 12 months (
2=30.78, df=3, P<0.001).
Diagnosis of depression
Table 5 shows the proportions of
participants in each centre who were no longer cases at follow up
interviews at six and 12 months. It also shows the percentage
differences between control and treatment groups in each centre, the
percentage and odds ratios for overall differences, and, at six months,
the numbers needed to treat to achieve the observed
differences.
|
unweighted (complete case analysis) and weighted
(to adjust for drop-out). In both analyses the centre effects were
treated as fixed as a straightforward weighted analysis was not
possible using xtlogit in STATA. Baseline data for the Beck
depression inventory, age, concurrent treatment with antidepressants
(yes or no), and diagnostic category (single, recurrent, dysthymia, adjustment, or other) were also included in the analysis. Using odds
ratios with 95% confidence limits, at six months the first method
shows a significant treatment effect for problem solving and an almost
significant effect for prevention of depression, whereas the weighted
analysis yields similar therapy effects, both falling just short of
significance (
=0.05). These analyses indicate a treatment effect,
with similar outcomes of the two therapies. The estimated common
therapy effect odds ratios are 0.50 (95% confidence interval 0.30 to
0.85) and 0.54 (0.32 to 0.91) for the unweighted and weighted analyses,
respectively. Ignoring drop-outs does not significantly bias estimates
of treatment effects. At 12 months, neither method shows any
differences between the two interventions and
controls.
|
Depressive symptoms and subjective function
Depressive symptoms were measured at each interview by the
Beck depression inventory, with lower figures indicating less
depressive symptoms. Subjective function was measured with the SF-36,
with higher scores indicating better subjective function. We present
data on three SF-36 domains, mental role, social function, and mental
health, as these are most relevant to a depression oriented intervention.
|
|
| |
Discussion |
|---|
|
|
|---|
Implications
Our study design breaks new ground in mental health
research in community settings by combining a population survey with a
randomised controlled trial. The outcomes of depression international
network is the first international multicentre randomised controlled
trial of psychological interventions for depression undertaken among
the general population. It is the largest trial to date of problem
solving treatment and the largest and most rigorously designed trial of
the course on prevention of depression.
Limitations
The differential in acceptability between problem solving
and prevention of depression may reflect differential accessibility.
Problem solving was usually delivered in the participants' homes.
Participants who were assigned to prevention of depression had to
travel, which may have reduced their likelihood of taking part. There
were greater time delays in organising group events, and the didactic
nature of the course on prevention of depression may have discouraged
participation by those with previous negative experiences of education.
Depressed patients may have felt stigmatised by their condition and
less inclined to participate in group activity than a private
individual process, particularly in close-knit rural areas such as
the Norwegian rural site.
Conclusions
Problem solving treatment and the course on prevention of
depression may be recommended as effective interventions for people
with depressive conditions in urban and rural community settings. This
is because they reduce severity and duration of depressive disorders
and improve subjective mental and social functioning. Our results
should influence psychological services in primary care, emphasising
treatments that are specific, brief, and easy to learn, with specific
implications for practice counsellors. They also provide encouragement
for depressed people who have not previously benefited from healthcare
interventions.
|
What is already known on this topic
Psychological interventions for depression are popular with the public, but evidence for their efficacy in community settings is limited Problem solving is an effective treatment for depression in primary care Group psychoeducation may be effective in healthcare and community settings What this study addsIt is feasible to undertake psychological interventions for depressive disorders in the context of community based surveys in a range of urban and rural settings across Europe Problem solving treatment seems more acceptable than the course on prevention of depression to depressed people in community settings Both problem solving treatment and the course on prevention of depression reduce the severity and duration of depressive disorders and improve subjective mental and social functioning |
| |
Acknowledgments |
|---|
The Outcome of Depression International Network Group is composed of academic colleagues and research and administrative staff who have worked on this part of the network's project. They are Gail Birkbeck, Trygve Børve, Maura Costello, Pim Cuijpers, Ioana Davies, Nicholas Fenlon, Mette Finne, Fiona Ford, Andres Gomes del Barrio, Claire Hayes, Ann Horgan, Tarja Koffert, Nicola Jones, Lourdes Lasa, Marja Lehtilä, Catherine McDonough, Erin Michalak, Christine Murphy, Anna Nevra, Teija Nummelin, and Britta Sohlman.
Contributors: All authors except GD and HP contributed to the conception and design of the study. HP and the Outcomes of Depression International Network Group were responsible for the collection and management of the data. GD coordinated the data analysis. All authors contributed to writing the paper. CD and GD will act as guarantors for the paper.
| |
Footnotes |
|---|
Funding: The project for the outcomes of depression international network was supported by the EC Biomed 2 programme (contract No BMH4-CT-1681), the English National Health Service Executive north west research and development office (contract No RDO/18/31), Spanish Fondo de Investigacion Sanitaria (contract No 96/1798), the Wales office of research and development (contract No RC092), the Norwegian Research Council, the Council for Mental Health, the Department of Health and Social Welfare, and the Finnish Pensions Institute of Agricultural Entrepreneurs (contract No 0339).
Competing interests: None declared.
| |
References |
|---|
|
|
|---|
| 1. | Ormel J, von Korff M, Ustun T, Pini S, Korten A, Oldehinkel T. Common mental disorders and disability across cultures. JAMA 1994; 272: 1741-1748[Abstract]. |
| 2. | Paykel ES, Priest RG. Recognition and management of depression in general practice: consensus statement. BMJ 1992; 161: 633-637. |
| 3. | Goldberg D, Huxley P. Common mental disorders: a biosocial model. London: Routledge, 1992. |
| 4. | Freemantle N, Long A, Mason A, Song F, Sheldon T, Watson P, et al. The treatment of depression in primary care York: NHS Centre for Reviews and Dissemination, 1993. |
| 5. |
Eccles M, Freemantle N, Mason J.
North of England evidence-based guideline development project: summary version of guidelines for the choice of antidepressants for depression in primary care.
Fam Pract
1999;
16:
103-111 |
| 6. | Frank E. Enhancing patient outcomes: treatment adherence. J Clin Psychiatry 1998; 58(s1): 11-14. |
| 7. |
Paykel ES, Hart D, Priest RG.
Changes in public attitudes to depression during the defeat depression campaign.
Br J Psychiatry
1998;
173:
519-522 |
| 8. |
Dowrick C, Casey P, Dalgard O, Hosman C, Lehtinen V, Vazquez-Barquero J-L, et al.
Outcomes of Depression International Network (ODIN): background, methods and field trials.
Br J Psychiatry
1998;
172:
359-363 |
| 9. | Hawton K, Kirk J. Problem-solving. In: Hawton K, Salkovskis PM, Kirk JW, Clark DM, eds. Cognitive behaviour therapy for psychiatric problems: a practical guide. Oxford: Oxford Medical, 1989:406-427. |
| 10. |
Mynors-Wallis L, Gath D, Lloyd-Thomas A, Tomlinson D.
Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care.
BMJ
1995;
310:
441-445 |
| 11. |
Mynors-Wallis L, Gath D, Day A, Baker F.
Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care.
BMJ
2000;
320:
26-30 |
| 12. | Lewinsohn P. The coping with depression course: review and future directions. Can J Behav Sci 1989; 21: 470-493. |
| 13. | Muñoz R. The depression prevention course (revised edition 1998). Unpublished manual. Available from the author: University of California, San Francisco, Department of Psychiatry. |
| 14. | Cuijpers P. A psychoeducational approach to the treatment of depression: a meta-analysis of Lewinsohn's `coping with depression' course. Behav Ther 1998; 29: 521-533[CrossRef]. |
| 15. | Muñoz R, Ying Y, Bernal G, Perez-Stable E, Sorensen J, Hargreaves W, et al. Prevention of depression with primary care patients: a randomized controlled trial. Am J Community Psychol 1995; 23: 199-222[CrossRef][Medline]. |
| 16. |
Wells K, Sherbourne C, Schoenbaum M, Duan N, Meredith L, Unutzer J, et al.
Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial.
JAMA
2000;
283:
212-220 |
| 17. |
Dunn G, Pickles A, Tansella A, Vazquez-Barquero J.
Two-phase epidemiological surveys in psychiatric research.
Br J Psychiatry
1999;
174:
95-100 |
| 18. | Beck A, Ward C, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571. |
| 19. | World Health Organization. Schedule for clinical assessment in neuropsychiatry: version 2.0. Geneva: WHO (Division of Mental Health), 1994. |
| 20. | Stewart A, Hays R, Ware J. The MOS short-form general health survey: reliability and validity in the patient population. Med Care 1998; 26: 724-732[CrossRef]. |
| 21. |
Hollis S, Campbell F.
What is meant by intention to treat analysis? Survey of published randomised controlled trials.
BMJ
1999;
319:
670-674 |
| 22. | Little R, Rubin D. Statistical analysis with missing data New York: Wiley, 1987. |
| 23. | Ayuso-Mateos J, Vazquez-Barquero J, Dowrick C, Lehtinen V, Dalgard O, Casey P, et al. Depressive disorders in Europe: prevalence figures from the ODIN study. Br J Psychiatry 2000 (in press). |
(Accepted 15 August 2000)
Read all Rapid Responses
What can you learn from this BMJ paper? Read Leanne Tite's Paper+